Publicaciones en las que colabora con CARMELO AGUIRRE GÓMEZ (29)

2024

  1. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

2023

  1. Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685

2022

  1. Subacute thyroiditis and COVID-19 vaccines: a case/non-case study

    Endocrine, Vol. 77, Núm. 3, pp. 480-485

2021

  1. Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study

    European Neuropsychopharmacology, Vol. 50, pp. 107-111

  2. SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database

    Journal of Clinical Pharmacology, Vol. 61, Núm. 2, pp. 187-192

  3. Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database

    Therapeutic Advances in Drug Safety, Vol. 12

2020

  1. Food groups, diet quality and colorectal cancer risk in the Basque Country

    World journal of gastroenterology, Vol. 26, Núm. 28, pp. 4108-4125

  2. Gene-Diet Interactions in Colorectal Cancer: Survey Design, Instruments, Participants and Descriptive Data of a Case-Control Study in the Basque Country

    Nutrients, Vol. 12, Núm. 8

2019

  1. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance)

    International Clinical Psychopharmacology, Vol. 34, Núm. 2, pp. 89-92

  2. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database

    American journal of therapeutics, Vol. 26, Núm. 5, pp. e589-e592

  3. Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population

    PLoS ONE, Vol. 14, Núm. 12

2018

  1. Aripiprazole and impulse control disorders: Higher risk with the intramuscular depot formulation?

    International Clinical Psychopharmacology, Vol. 33, Núm. 1, pp. 56-58

  2. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding

    European Journal of Clinical Pharmacology, Vol. 74, Núm. 11, pp. 1503-1511

2017

  1. Clozapine-Induced Cardiomyopathy in Parkinson's Disease

    Movement Disorders Clinical Practice

  2. El hipo en la Enfermedad de Parkinson

    Congreso SEFIG (13º. Alcalá de Henares. 2017)

  3. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

2016

  1. Adherence to guidelines for colorectal cancer prevention and its relationship to this cancer in the Basque country: a case-control study

    Annals of Oncology, Vol. 27, pp. vi168

  2. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

  3. Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: A case report and analysis of cases reported in the European pharmacovigilance database

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 3, pp. 368-370

2015

  1. Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database

    Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84